#361
|
|||
|
|||
Íó à ïî ññûëêå - òàì íå ñàìà ñòàòüÿ?
|
#362
|
|||
|
|||
Íåò, àáñòðàêò.
ÇÛ Äàæå åñëè áû áûë ïîëíûé òåêñò ñòàòüè, ÿ áû âñå ðàâíî åå íå ÷èòàë, âðåìåíè íà âñå íå õâàòèò... |
#363
|
|||
|
|||
Íî òàì î÷åíü âàæíûé âîïðîñ ðàññìàòðèâàåòñÿ, äàëåêî íå ïðàçäíûé. Ïðèìåíèòåëüíî âîò ê ñåáå - ÿ äî ñèõ ïîð â íåîïðåäåëåííîñòè, íå ìîãó ðåøèòü äëÿ ñåáÿ - ÷òî ïåðåâåøèâàåò - ðèñê äàòü òîë÷îê ðàçâèòèþ ðàññåÿííîãî ñêëåðîçà èëè ïîëüçà îò ïðèâèâêè. Îïàñåíèå ðàññåÿííîãî ñêëåðîçà îñòàíàâëèâàåò æåëàíèå ñäåëàòü ïðèâèâêó. Ïîýòîìó è õîòåëîñü áû ïîëó÷èòü îòâåò ñïåöèàëèñòîâ - íàñêîëüêî ïðèâèâêà ïðîòèâ ãåïàòèòà  óâåëè÷èâàåò ðèñê çàáîëåòü ÐÑ?
|
#364
|
|||
|
|||
Ýòîò îçíà÷àåò, ÷òî Âû "ïåðåâåëè ñâîé âîïðîñ"?
Òîãäà òåïåðü Âû ñìîæåòå åãî çàäàòü â ñîîòâåòñòâóþùåì ðàçäåëå (Íå çàáóäüòå âíà÷àëå ïðî÷èòàòü "Âàæíûå" òåìû) |
#365
|
||||
|
||||
Ïîäïèñü ê èëëþñòðàöèè. Shape of the scapholunate joint surface. (a) crescent (b) half moon
×åì crescent îòëè÷àåòñÿ îò half moon? Ñïàñèáî. |
#366
|
|||
|
|||
ß òàê ïîíèìàþ:
crescent [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì] èëè [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì] half moon [Èçîáðàæåíèÿ äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì] |
#367
|
||||
|
||||
•ïîëóìåñÿö (m)
n. half moon, demilune, moon when it is halfway through its cycle and is seen as a half circle •Ïîëóìåñÿö crescent •ïîëóìåñÿö Half moon ñèíîíèìû |
#368
|
|||
|
|||
Âîçìîæíî "ñåðïîâèäíûé" è "ïîëóëóííûé"
Íî ýòî ìîæíî îòíåñòè ñêîðåå íå ñòîëüêî ê ñàìîé ôîðìå ïîâåðõíîñòè ñóñòàâà, à âêóïå ñ âèäèìîé êîñòüþ? |
#369
|
|||
|
|||
Ïîíðàâèëîñü îò ïåðåâîä÷èêîâ...
Öèòàòà:
|
#370
|
|||
|
|||
Äîáðîãî âå÷åðà âñåì!
Ìîæåò ó êîãî óäà÷íûå âàðèàíòû ïåðåâîäà âûäåëåííîãî èìåþòñÿ? several national and international bone health guidelines being updated combination of BMD and clinical risk factors identified >28% of these women as candidates for bone-directed therapy have a large effect on acute fracture risk during active treatment = Òðàâìàòè÷åñêèé (ïîñòòðàâìàòè÷åñêèé) ïåðåëîì? total hip bone mineral density |
#371
|
||||
|
||||
Öèòàòà:
total hip - ýòî "âñåãî ïðîêñèìàëüíîãî îòäåëà áåäðåíîé êîñòè". Îñòàëüíûå âàðèàíòû, êîíå÷íî, æåñòü. |
#372
|
|||
|
|||
Ñïàñèáî.
Âîò åùå çàãàäêà: Consequently, side-effect profiles and management should be taken into account when selecting an antiresorptive agent to prevent or treat AIBL. Ïûòàþñü ïîíÿòü, management îòíîñèòñÿ ê ëå÷åíèþ ñîñòîÿíèÿ, ïî ïîâîäó êîòîðîãî íóæíû àíòèðåçîðáòèâíûå ïðåïàðàòû èëè ê ëå÷åíèþ ïîáî÷íûõ ýôôåêòîâ îò ýòèõ ïðåïàðàòîâ? |
#373
|
||||
|
||||
Ëå÷åíèå ïîáî÷íûõ ýôôåêòîâ.
|
#374
|
|||
|
|||
Ñêîðåå ïñèõîëîãè ñìîãóò ïîäñêàçàòü?
showed some support for cognitive– behavioral interventions, exercise, hypnosis, relaxation, and psychoeducation for fatigue.
Êîãíèòèâíî-ïîâåäåí÷åñêîå "âîçäåé÷òâèå"??? È êàê "ðåëàêñàöèþ" ïðàâèëüíî ïîíÿòü - îòïóñê èëè çàíÿòèÿ â ãðóïïàõ? Äÿêóþ. ;-) |
#375
|
||||
|
||||
Êîãíèòèâíî - ïîâåäåí÷åñêîå âìåøàòåëüñòâî è ðåëàêñàöèÿ â ñìûñëå ïðèìåíåíèÿ ðåëàêñàöèîííûõ òåõíèê.
__________________
Lead, follow, or get out of the way. — Thomas Paine |